The skin of an adult human being measures about 1.5 square metres and weighs approximately four kilos for an average-sized individual. It’s not only the largest organ in our body but is also our first major protective barrier, defending the body from bacteria, harmful chemicals and extreme temperatures. But what do its physical well-being and resilience depend on? A new study from Spain’s National Centre for Cardiovascular Research (CNIC) has revealed that the immune system may play a key role.

In this latest edition of News from the Lab, CaixaResearch researcher Andrés Hidalgo and “la Caixa” Foundation fellow Tommaso Vicanolo explain their new finding,

Long before the first robot hoover existed, the laws that would shape its relationship with humans had already been imagined. Almost a century before Sputnik 1 became the first artificial satellite in history, someone had dreamt it up in the pages of a book. Even cloning and the ‘de-extinction’ of species were conceived in the mind of a writer before science labs. Throughout history, science fiction has fuelled the imagination of researchers on countless occasions, driving advances that have come to change the world.

The laws of robotics in Isaac Asimov’s I, Robot (1950), space flight in Jules Verne’s From the Earth to the Moon (1865) and genetic engineering in H.G.

As defined by the World Health Organisation (WHO), health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. Health also lies in vaccines and advances in immunotherapy, in improvements in the living conditions of families, mothers and newborns, and in the search for cures for Alzheimer’s disease. And health also takes shape in any research that pushes the boundaries of knowledge, in all those scientific challenges that help us to find the solutions that transform the future and improve people’s lives.

As part of World Health Day, we explore the key role played by scientific excellence in the face of great biomedical challenges.

Tuberculosis is one of humanity’s oldest infectious diseases and the one that has caused the most deaths throughout history. In the last 200 years alone, it has claimed the lives of more than a billion people and is still the most lethal infectious disease today.

To address this major global health challenge, more and more progress is being made in prevention, diagnosis and treatment. The only vaccine available for the disease was developed in 1921 but there are currently 14 new vaccine candidates under clinical development, getting closer to being tested on humans.

There are social, economic and scientific challenges to eradicating tuberculosis but also promising advances that offer hope for the future.

On 12 March, the CaixaResearch Institute held its first public event with a lecture by Dr. Gabriel Rabinovich, Principal Investigator at the CaixaResearch Institute and a world leader in glycoimmunology.

In his presentation, “A Sweet Adventure from an Unexpected Discovery to the Design of New Therapies”, Dr. Rabinovich took us on a fascinating journey through his scientific career over the past 30 years. From a serendipitous discovery to its application in developing new therapeutic strategies with the potential to transform the treatment of cancer and autoimmune diseases.

The lecture was introduced by Dr. Josep Tabernero, Chairman of the Internal Scientific Committee of the CaixaResearch Institute and Director of the Vall d’Hebron Institute of Oncology (VHIO).